期刊文献+

环孢素致慢性肾毒性研究进展 被引量:8

Cyclosporine-induced chronic nephrotoxicity Progress
原文传递
导出
摘要 环孢霉素A一种真菌代谢产物,由11个氨基酸组成,能够有效减轻排斥反应,延长移植物半衰期,是临床应用的主要免疫抑制剂,被广泛应用于器官移植及一些免疫性疾病,明显改善了器官和骨髓移植者的生存率,然而也伴随着严重的副作用,慢性肾毒性尤为突出,发生率高(30%~74%),对肾脏而言,将损害移植肾脏本身。慢性肾毒性的最终表现为肾小管萎缩,肾小球硬化,间质纤维化等,但其分子机制目前仍不清楚。 Cyclosporine A is a kind of fungus metabolite, consisting of 11 amino acids, which can effectively reduce rejection and extend the half-life of transplanted organ. It is the main clinical immunosuppressive, is widely used in organ transplants and a number of autoimmune diseases , which greatly improved the survival rate of organ and bone marrow transplant recipients, but its serios side effects have gradually been recognized, especially the chronic nephrotoxicity. The high incidence (30% ~70% )will damage the transplanted kidneys. The ultimate clinical performance of chronic nephrotoxicity are tubular atrophy, glomerular sclerosis, interstitial fibrosis, but its molecular mechanism is still unclear.
出处 《现代生物医学进展》 CAS 2009年第22期4368-4370,4332,共4页 Progress in Modern Biomedicine
关键词 环孢霉素A 慢性肾毒性 器官移植 cyclosporine A chronic nephrotoxicity organ transplantation
  • 相关文献

参考文献4

二级参考文献21

  • 1Thomas U. Neurohormonal modulation in cardiovascular.Am Heart Journal, 2000,139(NO. 1part 2) :2 - 6.
  • 2Burns KD. Angiotensin II and its receptors in the diabetic kidney. Am J Kidney Dis, 2000,36(3) :449 - 467.
  • 3Burnier M, Brunner HR. Angiotensin II receptor antagonists. The Lancet, 2000,355 : 637 - 645.
  • 4Ccoper ME, Webb RL, de Gasparo M. Angiotensin receptor blockers and the kidney: possible advantages over ACE inhibition? Cardiovas Drug Rev, 2001,19(1) : 75 - 86.
  • 5Oikawa T, Freeman M, Lo W, et al. Modulation of plasminogen activator inhibitor- 1 in vivo: A new mechanima for the anti - fibrotic effect of renin - angiotensin inhibition.Kidney Int, 1997,51:164- 172.
  • 6Kim S, Iwao H. Molecular and cellular mechanism of angiotensin II - mediated cardiovascular and renal disease.Pharmacology Rev, 2000 ,52( 1 ) : 11 - 34.
  • 7Ardaillou R, Chansel D, Chatziantoniou C, et al. Mesangial AT1 receptor: signaling and regulation. J Am Soc Nephro,1999, (Suppl 11):40-46.
  • 8Pupilli C, Lasagni L, Romagnani P, et al. Angiotensin II stimulate the synthesis and secretion of vascular permeability factor/vascular endothelial growth factor in human mesangial cells. J Am Soc Nephro, 1999,10(2) :245 - 255.
  • 9Border WA, Noble NA. Effect of maximal reduction of angiotensin in renal fibrosis: Bad news- good news from a pediatric mouse. Am J Kidney Dis, 2000,35(4) :773 - 776.
  • 10Rerelle JP, Hertig A, Nguyen G, et al. Plasminogen activator inhibitor type- 1 is a potential target in renal fibrogenesis. Kidney Int, 2000,58(5) :251-259.

共引文献47

同被引文献84

引证文献8

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部